NCT00329563

Brief Summary

The overall goal of this study is to determine the feasibility of initiating hypothermia in cardiac arrest patients as soon as possible in the field. In this pilot study we will randomize 125 patients after return of spontaneous circulation (ROSC) to hypothermia with rapid infusion of 2 liters of 4oC Normal Saline IV solution over 20 to 30 minutes, IV sedation and muscle paralysis or to standard of care following ROSC. The primary objectives of this study will be to determine whether temperature of 33-34oC can be achieved and maintained using this strategy. The primary outcome measures will include: temperature changes of the patients at time of admission to the hospital. Secondary analysis will include determining if the proportion of patients discharged from the hospital is increased in the group receiving hypothermia. If this initial pilot study can demonstrate feasibility in achieving and maintaining hypothermia, a larger randomized clinical trial to test the hypothesis that hypothermia initiation in the field will increase the proportion of patients surviving following cardiac arrest will be planned.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2004

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 24, 2006

Completed
Last Updated

April 17, 2017

Status Verified

April 1, 2017

First QC Date

May 22, 2006

Last Update Submit

April 13, 2017

Conditions

Keywords

Cardiac ArrestHypothermia

Outcome Measures

Primary Outcomes (1)

  • Temperature difference between first field temperature and hospital arrival temperature

    less than 60 minutes

Secondary Outcomes (2)

  • Survival to discharge from hospital

    Between 2 -30 days

  • Awakening in the hospital

    between 2-30 days

Study Arms (2)

Cold fluid

EXPERIMENTAL
Drug: Up to 2 liter infusion of cold 4 degree C normal saline

control, standard of care

NO INTERVENTION

Interventions

Patients randomized to field cooling will receive up to 2 liters of 4oC normal saline. Control patients will receive standard of care following resuscitation.

Cold fluid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resuscitated out-of-hospital cardiac arrest defined as having a palpable pulse comatose IV access Intubated

You may not qualify if:

  • age less than 18 traumatic cause of cardiac arrest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart ArrestHypothermia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Francis Kim, MD

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Medicine, Division of Cardiology

Study Record Dates

First Submitted

May 22, 2006

First Posted

May 24, 2006

Study Start

November 1, 2004

Study Completion

March 1, 2006

Last Updated

April 17, 2017

Record last verified: 2017-04